Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00099697 · ClinicalTrials.gov registry record · NA

Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans

A NA study of Obesity and Aging, sponsored by National Institute on Aging (NIA).

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT00099697: Completed NA study of Obesity and Aging, sponsored by National Institute on Aging (NIA).

NCT00099697 is a NA study of Obesity and Aging that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00099697, a NA study of Obesity and Aging, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether DHEA replacement therapy decreases abdominal fat and improves insulin sensitivity.

Interventions

  • DRUG DHEA

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2001-06
Est. Completion 2004-02
Phase NA
National Institute on Aging (NIA)

131 total trials

What the finished NCT00099697 record still lists

NCT00099697 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which DHEA is the first listed.

NCT00099697 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00099697 about?

NCT00099697 is a clinical study titled "Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans". The purpose of this study is to determine whether DHEA replacement therapy decreases abdominal fat and improves insulin sensitivity.

What is the current status of trial NCT00099697?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2001-06. Estimated completion is 2004-02.

What conditions does trial NCT00099697 study?

This clinical trial studies the following conditions: Obesity, Aging, Insulin Resistance.

What interventions are being tested in trial NCT00099697?

The interventions under investigation include: DHEA (DRUG).

Who is sponsoring clinical trial NCT00099697?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00099697 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00099697's enrollment target sits among peer trials

56 689th of 1053 higher than 360 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00099697, the US trial registry maintained by the National Library of Medicine. NCT00099697 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.